NIMH Initiates PET Imaging Study with New Tracer 11C-ARMI for Brain Research
The National Institute of Mental Health is testing a new radioactive tracer, 11C-ARMI, in healthy individuals to evaluate its effectiveness in imaging brain function.
Asset / Drug
Drug and asset intelligence for NIMH with 7 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.